Naglaa F Khedr

11PUBLICATIONS
7CO-AUTHORS
Medical infection agents (incl. prions)Food properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)ChiropracticMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 12, 2026
Paraxanthine and azilsartan attenuate gentamicin-induced renal fibrosis via modulation of TGF-β1/Smad3/7 signaling and miRNA-21/miRNA-200b expression.

|Apr 17, 2026
Docosahexaenoic acid is comparable to vildagliptin in improving hyperglycemia and pancreatic insulin signaling of diabetic rats via SIRT1/Akt/PI3K pathway.

|Mar 20, 2026
Enhanced antitumor activity of atorvastatin and luteolin, with or without doxorubicin, in a solid Ehrlich carcinoma mouse model: modulation of ABC transporters, telomerase, and cancer stem cells.

Ghada M Al-Ashmawy, Nahla E El-Ashmawy, Omnia B Hamada

|Jun 25, 2025
Berberine-Induced Cytotoxicity in Breast Cancer Is Mediated by Reversal of EMT and Repression of Sirtuin 1/AKT Signaling Pathways.

Nahla E El-Ashmawy, Eman G Khedr, Samar A El-Adawy

|May 19, 2025
Proanthocyanidin and mitoglitazone suppress lipogenesis by targeting ferroptosis in metabolic dysfunction-associated steatohepatitis.

Sohair M Abd El-Naby, Naglaa F Khedr, Nahla E El-Ashmawy

|Mar 27, 2025
Evaluation of prescribing patterns of sodium valproate in neurological disease patients: a quasi-experimental pretest-posttest design study.

Rehab H Werida, Salima El-Sherif, Rania Shoshan

Pageof 2

Frequent Collaborators

4 joint publications

Rehab H Werida

2 joint publications

Nahla E El-Ashmawy

1 joint publications

Lamiaa Khedr

1 joint publications

Amera O Ibrahim